Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Several Indian companies are preparing to enter the market: Alkem Laboratories has started clinical trials for semaglutide and plans to launch close to patent expiration in March 2026. Biocon is developing its own version of Wegovy and aims to be one of the early players in the market, targeting a launch in 2026 or shortly after
macros (1 serving): 30g protein ~340 kcal Cost: ~$2.80 5
DISCLAIMER This product is intended for laboratory research use only
That means patients who want baseline metabolic data, kidney or liver monitoring, or structured nutrition counseling may still need outside care regardless of which platform they choose
Um, and so we're not being liberal here with how it's being prescribed
The study design followed rigorous protocols
US$ 23.25
US$ 25.30
US$ 25.55
